Terminal
Stocks
Spotlight
Research

Stocks
Healthcare
NASDAQ
IART

Market Cap: $1.21B

IC

Integra LifeSciences Holdings Corporation

IART

NASDAQ (NASDAQ Global Select)USD

Overview News Analyst Reports Financials Politician Trades Insider Trades Executive Patents Earnings Surprise

By Cashu Finance. Providing market news, analysis, and research for investors worldwide.

Company

Stocks About Advertisers Brokers Contact

Legal

Terms of Service Privacy Policy

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Finance is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Finance is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Finance and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

Financials

Profitability

Gross Profit Margin53.74%

EBITDA Margin15.10%

EBIT Margin5.83%

Pre-tax Margin-0.01%

Net Profit Margin-0.44%

Earnings Yield-0.60%

Valuation Multiples

Price / Book1.15

Price / Sales0.73

Price / Earnings-168.11

PEG-1.68

Forward PEG-27.18

EV / Sales1.84

EV / EBITDA12.18

EV / Operating Cash Flow35.52

EV / Free Cash Flow78.20

Price / Free Cash Flow31.10

Price / Operating Cash Flow14.20

Cash Flow & Capital

Free Cash Flow / Share$0.5

Operating Cash Flow / Share$1.09

Free Cash Flow Yield3.21%

Capex / Revenue2.83%

Capex / Operating Cash Flow54.58%

Capex / Depreciation0.61

Stock Compensation / Revenue0.69%

Dividend Payout Ratio0.00%

Dividend Yield0.00%

Liquidity & Leverage

Current Ratio3.40

Quick Ratio1.98

Cash Ratio0.62

Debt / Assets0.57

Debt / Capital0.66

Debt / Equity1.94

Long-Term Debt / Capital0.63

Debt / Market Cap1.55%

Net Debt / EBITDA7.34

Solvency Ratio0.06

Financial Leverage3.41

Efficiency & Working Capital

Asset Turnover0.46

Fixed Asset Turnover2.82

Inventory Turnover1.55

Receivables Turnover6.17

Payables Turnover8.67

Days Sales Outstanding59.19

Days Inventory Outstanding235.61

Days Payables Outstanding42.12

Operating Cycle294.79

Cash Conversion Cycle252.68

Working Capital Turnover1.99

Returns & Quality

Return on Equity-0.69%

Return on Assets-0.20%

Return on Invested Capital19.92%

ROCE20.25%

Return on Tangible Assets-0.39%

Operating Return on Assets18.31%

Income Quality-12.00

Tax Burden40.46

Interest Burden-0.00

Balance Sheet & Intrinsic Metrics

Enterprise Value$3.03B

Invested Capital$3.14B

Working Capital$833.5M

Tangible Asset Value$-667.86M

Net Current Asset Value$-1.35B

Graham Net-Net-$23.22

Book Value / Share$13.44

Tangible Book Value / Share-$8.54

Cash / Share$3.51

Financial Health Scores

Piotroski Score5

Altman Z-Score1.28

Revenue$1.65B

EBIT$96.06M

Market Cap$1.21B

Working Capital$833.5M

Retained Earnings$427.15M

Total Assets$3.59B

Total Liabilities$2.54B